Home » Topics » BioWorld Science

BioWorld Science
RSS

NIAID reports phase IIb results on VRC-01 for HIV prevention

Jan. 27, 2021

FDA clears IND for anti-4-1BB therapeutic monoclonal antibody EU-101

Jan. 27, 2021

BriaCell reports data from monotherapy and combination therapy studies of Bria-IMT

Jan. 27, 2021

DPP-4 inhibitor sitagliptin prevents incidence of GvHD after allogeneic HSCT in AML

Jan. 27, 2021

Syndesi reports phase I data on SV2A modulator SDI-118

Jan. 27, 2021

Primary endpoint met in ACTIVATE-T trial of mitapivat in transfused patients with PK deficiency

Jan. 27, 2021

Sorrento reports preliminary phase Ib results on COVI-MSC for COVID-19

Jan. 27, 2021

FDA allows Cardif Oncology to proceed with phase II trial of onvansertib in PDAC

Jan. 27, 2021

FDA approves phase II/III HIBISCUS trial of traumakine in patients with COVID-19

Jan. 27, 2021

Rhythm presents positive clinical data and development update for setmelanotide

Jan. 27, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...